IPO registrations (S-1, F-1) · Registrants
Verastem, Inc.
- SEC CIK
- 1526119 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2011-11-03, last 2012-01-13; 1 initial registration, 3 amendments
- Outcome
- Final prospectus filed 2012-01-27; declared effective 2012-01-26
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- MA
- Business address
- 117 KENDRICK STREET, SUITE 500, Needham, MA 02494
- EIN
- 27-3269467
- Ticker
- VSTM (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Verastem, Inc. on the corporate pages
Offering terms
- Proposed price range
- $9.00–$11.00 per share (S-1/A filed 2012-01-13)
- Final price
- $10.00 per share, within the range (424B4 filed 2012-01-27, an initial public offering)
- Shares sold
- 5,500,000
- Gross proceeds
- $55,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol VSTM
- Lead underwriters
- UBS (1,925,000 shares); Leerink Partners (1,650,000 shares)
- Syndicate
- Lazard (825,000); Oppenheimer (825,000); Rodman & Renshaw (275,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: VERASTEM, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Verastem, Inc. Fuzzy (name and state)
- Business registration: Verastem, Inc. Fuzzy (name and state)
- Business registration: Verastem, Inc. Fuzzy (name and state)
- Business registration: VERASTEM, INC. Fuzzy (name and state)
- Business registration: VERASTEM, INC. Fuzzy (name and state)
- Business registration: VERASTEM, INC. Fuzzy (name and state)
- Business registration: VERASTEM, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: VERASTEM, INC. EXACT (EIN (EXACT))
- Federal award recipient: VERASTEM, INC. Fuzzy (name and state)
- Form D issuer: Verastem, Inc. EXACT (CIK (EXACT))
- SEC filer: Verastem, Inc. EXACT (CIK (EXACT))
- Person page: Henri A Termeer Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Julie B Feder Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer))
Filings 9
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2011-11-03 | S-1 | S-1 (registration) | Verastem, Inc. | 0001047469-11-008951 ↗ |
| 2011-12-07 | S-1/A | S-1/A (amendment) | Verastem, Inc. | 0001047469-11-009955 ↗ |
| 2011-12-22 | S-1/A | S-1/A (amendment) | Verastem, Inc. | 0001047469-11-010197 ↗ |
| 2012-01-13 | S-1/A | S-1/A (amendment) | Verastem, Inc. | 0001047469-12-000187 ↗ |
| 2012-01-26 | S-1MEF | S-1MEF (added securities) | Verastem, Inc. | 0001104659-12-004310 ↗ |
| 2012-01-26 | EFFECT | EFFECT (declared effective) | Verastem, Inc. | 9999999995-12-000315 ↗ |
| 2012-01-27 | 424B4 | 424B4 (final prospectus) | Verastem, Inc. | 0001047469-12-000412 ↗ |
| 2013-02-14 | EFFECT | EFFECT (declared effective) | Verastem, Inc. | 9999999995-13-000531 ↗ |
| 2014-01-08 | EFFECT | EFFECT (declared effective) | Verastem, Inc. | 9999999995-14-000072 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2012-01-13 | S-1/A | registration statement | $9.00–$11.00 | 4,500,000 | - | Nasdaq VSTM | 5 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 5 | document ↗ | |
| 2012-01-27 | 424B4 | final prospectus | $10.00 | 5,500,000 | $55,000,000 | Nasdaq VSTM | 5 | primary document; price sentence, shares headline, proceeds table, underwriting table 5, cover names 5 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| ALDRICH RICHARD | Director; Director,TenPercentOwner | 26 | 2012–2014 | ||
| Bessemer Venture Partners VII Institutional L.P. | Director,TenPercentOwner | 3 | 2012 | ||
| Bessemer Venture Partners VII L.P. | Director,TenPercentOwner | 3 | 2012 | ||
| BVP VII SPECIAL OPPORTUNITY FUND LP | Director,TenPercentOwner | 3 | 2012 | ||
| CLARKE JOHN K | Director | 10 | 2012–2013 | ||
| Deer Management Co. LLC | Director,TenPercentOwner | 4 | 2012 | ||
| Forrester Robert | Director,Officer; Officer | Chief Operating Officer; President and C.E.O.; President and CEO; PRESIDENT AND CEO; President and COO; President & CEO; President, CEO and Director | 29 | 2012–2019 | |
| GADICKE ANSBERT | Director | 3 | 2012 | ||
| Gupta Piyush | TenPercentOwner | 2 | 2012 | ||
| Kraus Stephen | Director | 3 | 2012 | ||
| LANDER ERIC S | TenPercentOwner | 1 | 2012 | ||
| Longwood Fund, L.P. | TenPercentOwner | 3 | 2012–2014 | ||
| Pachter Jonathan | Officer | VP, Head of Research | 10 | 2012–2014 | |
| TERMEER HENRI A | Director | 9 | 2012–2015 | person page Fuzzy | |
| Weinberg Robert A | TenPercentOwner | 1 | 2012 | ||
| Westphal Christoph H | Director,Officer; Director,Officer,TenPercentOwner; Director,TenPercentOwner | Chief Executive Officer; Executive Chairman; President and C.E.O.; President and CEO; President & Chief Exec Officer | 30 | 2012–2015 | |
| CHP III LP | TenPercentOwner | 8 | 2012–2013 | ||
| CHP III Management, L.L.C. | TenPercentOwner | 2 | 2012 | ||
| Deer VII & Co. L.P. | Director,TenPercentOwner | 2 | 2012 | ||
| Deer VII & Co. Ltd. | Director,TenPercentOwner | 2 | 2012 | ||
| EVNIN LUKE | Other | 2 | 2012 | ||
| Foley Todd | Other | 2 | 2012 | ||
| KAILIAN VAUGHN M | Other | 2 | 2012 | ||
| MPM ASSET MANAGEMENT INVESTORS BV5 LLC | Other | 1 | 2012 | ||
| MPM BIOVENTURES V GP LLC | Other | 2 | 2012 | ||
| MPM BIOVENTURES V LLC | Other | 2 | 2012 | ||
| MPM BIOVENTURES V, L.P. | Other | 2 | 2012 | ||
| Scopa James Paul | Other | 2 | 2012 | ||
| St Peter Steven | Other | 2 | 2012 | ||
| Vander Vort John | Other | 2 | 2012 | ||
| Phanstiel S. Louise | Director; Other | 11 | 2012–2019 | ||
| Horobin Joanna | Officer | Chief Medical Officer | 5 | 2012–2015 | |
| Kauffman Michael | Director; Director,Officer | President of Development | 22 | 2012–2026 | |
| Lawton Alison Frances | Director | 10 | 2012–2019 | ||
| Paterson Dan | Director,Officer; Officer | Cheif Business Officer; Chief Business Officer; Chief Operating Officer; CHIEF OPERATING OFFICER; Head of Corp. Dev, Diagnostics; Head of Corp. Dev.,Diagnostics; President and CEO; President and COO | 72 | 2012–2026 | |
| SHERWIN STEPHEN A | Director | 6 | 2013–2015 | ||
| GREEN JOHN B | Officer | Chief Financial Officer | 10 | 2013–2016 | |
| Singh Monica | Officer | General Counsel | 5 | 2014–2015 | |
| BARBERICH TIMOTHY J | Director | 16 | 2014–2021 | ||
| FRIEDMAN PAUL A | Director | 5 | 2014–2016 | ||
| Berk Gregory | Officer | Chief Medical Officer; CHIEF MEDICAL OFFICER | 4 | 2016–2017 | |
| Chiapponi Joseph | Officer | Vice President of Finance | 3 | 2016–2017 | |
| Wendel Bruce | Director | 6 | 2016–2020 | ||
| Rowinsky Eric K | Director | 14 | 2017–2026 | ||
| Feder Julie B | Officer | CFO, PFO and PAO; Chief Financial Officer | 4 | 2017–2018 | person page Fuzzy |
| Stuglik Brian M | Director; Director,Officer; Officer | Chief Executive Officer | 38 | 2017–2026 | |
| Le NgocDiep T. MD, PhD | Officer | Chief Medical Officer | 5 | 2017–2018 | |
| Bloom Steven H. | Officer | Chief Strategy Officer | 6 | 2017–2019 | |
| Lobacki Joseph M | Officer | Executive VP & CCO | 5 | 2018–2019 | |
| Gagnon Robert E. | Director; Officer | Chief Financial Officer | 35 | 2018–2025 | |
| Consylman Gina | Director | 5 | 2018–2021 | ||
| Ridgeback Capital Investments L.P. | TenPercentOwner | 2 | 2020 | ||
| Ridgeback Capital Investments Ltd. | TenPercentOwner | 2 | 2020 | ||
| Ridgeback Capital Management LP | TenPercentOwner | 2 | 2020 | ||
| Kolchinsky Peter | TenPercentOwner | 3 | 2020 | ||
| RA Capital Healthcare Fund LP | TenPercentOwner | 3 | 2020 | ||
| RA CAPITAL MANAGEMENT, L.P. | TenPercentOwner | 3 | 2020 | ||
| Shah Rajeev M. | TenPercentOwner | 3 | 2020 | ||
| JOHNSON JOHN | Director | 11 | 2020–2026 | ||
| Neumann Frank | Officer | Chief Medical Officer | 3 | 2021 | |
| Bunn Paul A. | Director | 11 | 2021–2026 | ||
| Solomon Lesley Kim | Director | 4 | 2021–2022 | ||
| ROBERTSON MICHELLE | Director | 9 | 2021–2026 | ||
| BIOTECHNOLOGY VALUE FUND II LP | Other | 1 | 2022 | ||
| BIOTECHNOLOGY VALUE FUND L P | Other | 1 | 2022 | ||
| Biotechnology Value Trading Fund OS LP | Other | 1 | 2022 | ||
| BVF GP HOLDINGS LLC | TenPercentOwner | 1 | 2022 | ||
| BVF I GP LLC | Other | 1 | 2022 | ||
| BVF II GP LLC | Other | 1 | 2022 | ||
| BVF INC/IL | TenPercentOwner | 1 | 2022 | ||
| BVF PARTNERS L P/IL | TenPercentOwner | 1 | 2022 | ||
| BVF Partners OS Ltd. | Other | 1 | 2022 | ||
| LAMPERT MARK N | TenPercentOwner | 1 | 2022 | ||
| Kapur Anil | Director | 6 | 2022–2026 | ||
| Calkins Daniel | Officer | Chief Financial Officer; Vice President of Finance | 36 | 2022–2026 | |
| Tollefson Karin Anna | Director | 5 | 2023–2026 | ||
| Ros Matthew | Officer | Chief Operating Officer | 2 | 2025 | |
| BAILEY MICHAEL P | Director | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2020-03-06 | Verastem, Inc. | Pharmaceuticals | $100,000,000 | $100,000,000 | 21 | 1 |
| 2020-01-07 | Verastem, Inc. | Pharmaceuticals | $4,829,628 | $4,829,628 | 4 | 1 |
| 2014-03-06 | Verastem, Inc. | Biotechnology | $3,898,326 | $3,898,326 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Verastem, Inc. | MA | State business registries | name and state |
| Business registration | Verastem, Inc. | MA | State business registries | name and state |
| Business registration | Verastem, Inc. | MA | State business registries | name and state |
| Business registration | VERASTEM, INC. | MA | State business registries | name and state |
| Business registration | VERASTEM, INC. | MA | State business registries | name and state |
| Business registration | VERASTEM, INC. | MA | State business registries | name and state |
| Business registration | VERASTEM, INC. | MA | State business registries | name and state |
| Business registration | VERASTEM, INC. | MA | State business registries | EIN (EXACT, as the state registration reports it) |
| Federal award recipient | VERASTEM, INC. | MA | Federal spending (USAspending) | name and state |
| Form D issuer | Verastem, Inc. | MA | Form D private offerings | CIK (EXACT) |
| Paying company | Verastem, Inc. | MA | Open Payments (drug and device company payments) | name and state |
| Patent assignee | Verastem, Inc. | MA | Patents (USPTO) | name and state |
| SEC filer | Verastem, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Verastem Inc. | MA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | VERASTEM, INC. | EIN (EXACT) | ||
| Person page | Henri A Termeer | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Julie B Feder | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.